Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Biochemistry, Iron Absorption

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Biochemistry, Iron Absorption

Thomas Ems et al.
Free Books & Documents

Excerpt

Iron is an essential element of various metabolic processes in humans, including DNA synthesis, electron transport, and oxygen transport. Unlike other minerals, iron levels in the human body are controlled only by absorption. The mechanism of iron excretion is an unregulated process arrived at through loss in sweat, menstruation, shedding of hair and skin cells, and rapid turnover and excretion of enterocytes. In the human body, iron exists mainly in erythrocytes as the heme compound hemoglobin (approximately 2 g of iron in men and 1.5 g in women), to a lesser extent in storage compounds (ferritin and hemosiderin) and in muscle cells as myoglobin. Iron is also found bound to proteins (hemoprotein) and non-heme enzymes involved in oxidation-reduction reactions and the transfer of electrons (cytochromes and catalase).

Additionally, approximately 2.2% of total body iron is found in the so-called labile pool, a poorly defined and reactive pool of iron that forms reactive oxygen species via the Fenton Reaction, which forms complexes with a drug class known as chelators. Iron chelators treat iron overload, a condition often caused by transfusion therapies used to treat thalassemias and other anemias.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Thomas Ems declares no relevant financial relationships with ineligible companies.

Disclosure: Kayla St Lucia declares no relevant financial relationships with ineligible companies.

Disclosure: Martin Huecker declares no relevant financial relationships with ineligible companies.

References

    1. Rodgers GM, Gilreath JA. The Role of Intravenous Iron in the Treatment of Anemia Associated with Cancer and Chemotherapy. Acta Haematol. 2019;142(1):13-20. - PubMed
    1. Gómez-Ramírez S, Bisbe E, Shander A, Spahn DR, Muñoz M. Management of Perioperative Iron Deficiency Anemia. Acta Haematol. 2019;142(1):21-29. - PubMed
    1. Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron Deficiency Anemia in Chronic Kidney Disease. Acta Haematol. 2019;142(1):44-50. - PubMed
    1. DeLoughery TG. Safety of Oral and Intravenous Iron. Acta Haematol. 2019;142(1):8-12. - PubMed
    1. Chuncharunee S, Teawtrakul N, Siritanaratkul N, Chueamuangphan N. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand. PLoS One. 2019;14(3):e0214148. - PMC - PubMed

Publication types

LinkOut - more resources